18.06.2009
opracowanie na podstawie: Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial
C.J. van Marrewijk, S. Mujakovic, G.A.J. Fransen, M.E. Numans, N.J. de Wit, J.W.M. Muris, M.G.H. van Oijen, J.B.M.J. Jansen, D.E. Grobbee, J.A. Knottnerus, R.J.F. Laheij
The Lancet, 2009; 373: 215–225